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Abstract
Background: Hypertonicity, such as induced by high NaCl, increases the activity of the transcription factor TonEBP/OREBP
whose target genes increase osmoprotective organic osmolytes and heat shock proteins.
Methodology: We used mass spectrometry to analyze proteins that coimmunoprecipitate with TonEBP/OREBP in order to
identify ones that might contribute to its high NaCl-induced activation.
Principal Findings: We identified 20 unique peptides from Mediator of DNA Damage Checkpoint 1 (MDC1) with high
probability. The identification was confirmed by Western analysis. We used small interfering RNA knockdown of MDC1 to
characterize its osmotic function. Knocking down MDC1 reduces high NaCl-induced increases in TonEBP/OREBP
transcriptional and transactivating activity, but has no significant effect on its nuclear localization. We confirm six
previously known phosphorylation sites in MDC1, but do not find evidence that high NaCl increases phosphorylation of
MDC1. It is suggestive that MDC1 acts as a DNA damage response protein since hypertonicity reversibly increases DNA
breaks, and other DNA damage response proteins, like ATM, also associate with TonEBP/OREBP and contribute to its
activation by hypertonicity.
Conclusions/Significance: MDC1 associates with TonEBP/OREBP and contributes to high NaCl-induced increase of that
factor’s transcriptional activity.
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Introduction
Although interstitial NaCl concentration normally is extremely
high in the renal medulla, its cells are protected by accumulation
of compatible organic osmolytes [1] and expression of heat shock
proteins [2]. These protective responses are mediated by the
transcription factor, Tonicity-responsive Enhancer/Osmotic Re-
sponse Element-Binding Protein (TonEBP/OREBP, NFAT5)
[3,4]. High NaCl activates TonEBP/OREBP, which increases
the transcription of genes whose protein products are involved in
accumulation of organic osmolytes, including glycine betaine
(BGT1, betaine/amino butyric acid transporter, SLC6A12), myo-
inositol (SMIT, sodium-myo-inositol cotransporter, SLC5A3),
glycerophosphocholine (Neuropathy Target Esterase, NTE,
PNPLA6) and sorbitol (aldose reductase, AKR1B1) [5]. To-
nEBP/OREBP also increases transcription of Heat Shock Protein
70 (Hsp70-2, HSPA1B) [6]. High NaCl increases transcriptional
activity of TonEBP/OREBP by several mechanisms. It causes
TonEBP/OREBP to translocate to the nucleus [3,4], increases the
mRNA and protein abundance of TonEBP/OREBP [3,4],
increases activity of the TonEBP/OREBP transactivation domain
(TAD) [7], and increases phosphorylation of TonEBP/OREBP
[8]. Several different protein kinases are known to contribute to
activation of TonEBP/OREBP, namely p38 MAP kinase
(MAPK14) [9], tyrosine kinase Fyn (FYN) [9], protein kinase A
(PKAcs, PRKACA) [10] and Ataxia Telangiectasia Mutated
kinase (ATM) [11]. All contribute to high-NaCl-induced activation
of TonEBP/OREBP, but no individual one is sufficient for full
activation [5].
TonEBP/OREBP is part of a large protein complex [3]. Some of
the other proteins in this complex are already known, based on
coimmunoprecipitation with TonEBP/OREBP, including PKAcs
[10], ATM [11], poly (ADP-ribose) polymerase 1 (PARP1) [12],
heat shock protein 90 (HSP90, HSP90AA1) [12], activator protein 1
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12108(AP-1,FOS/JUN)[13] and RNA HelicaseA (RHA,DHX9)[12,14],
all of which have been shown to regulate activation of TonEBP/
OREBP. Any additional proteins that physically associate with
TonEBP/OREBP are candidates for participation in the transcrip-
tional complex or signaling cascade. In the present study we used
mass spectrometry to identify proteins that immunoprecipite in
association with TonEBP/OREBP. We identify mediator of DNA
damage checkpoint 1 (MDC1) as one of them, and find that it
contributes to activation of TonEBP/OREBP. MDC1 is a DNA
damage response protein, which is significant since hypertonicity
reversibly increases DNA breaks and other DNA damage response
proteins, like ATM [11], also associate with TonEBP/OREBP and
contribute to its activation by hypertonicity.
Results
Identification by mass spectrometry of MDC1 as a
TonEBP/OREBP-associated protein
To identify proteins that associate with and, thus, possibly
regulate or support TonEBP/OREBP activity we immunoprecip-
itated stably transfected TonEBP/OREBP-1-547-V5 from nuclear
and cytoplasmic extracts of HEK293 cells 2 hours after osmolality
was changed from 300 to 200 or 500 mosmol/kg. We studied
transfected TonEBP/OREBP because, like other transcription
factors, the abundance of native TonEBP/OREBP protein is low.
Also, the cells do not tolerate continuous over expression of the full
length protein [12]. TonEBP/OREBP peptides were present in
both nuclear and cytoplasmic fractions from cells at 300 mosmol/
kg in 9 independent experiments, using either arginase or trypsin
for proteolysis. There were up to 9 unique peptides in a single
sample. MDC1 was also present in multiple independently
prepared samples at both 200 and 500 mosmol/kg. Table 1 lists
20 different peptides from MDC1 that were identified with high
probability. Representative spectra for four peptides are shown in
Figure 1.
Identification by mass spectrometry of phosphorylation sites in MDC1. We
also identified phosphorylated amino acids in MDC1, namely
S168, S299, T301, S329, S453, T455 (Table 2). High Ascores (27–
153) confirm the identifications (Ascore .19 predicts .99%
probability of correct identification). These phosphorylation sites
were previously reported [15–18]. Also, S299, T301, and S453
were reported to be phosphorylated in vitro by recombinant CK2
[18].
Confirmation by immunoblot of identification of MDC1
Osmolality bathing HEK293 cells stably expressing TonEBP/
OREBP-1-547-V5 or empty vector-V5 was increased to 500 mos-
mol/kg by adding NaCl for 1, 3 and 6 h. Anti-V5 immunopre-
cipitates from whole cell extracts were analyzed by Western blot.
MDC1 is present in immunoprecipitates from cells transfected
with TonEBP/OREBP-V5, but not from cells transfected with
empty vector-V5 (Fig. 2A). MDC1 is a large protein; its bands run
just above 250 kDa, which is the largest marker that we used.
Further, immunoprecipitates with anti-MDC1 from nuclear
extracts of the stably transfected HEK293 cells contain To-
nEBP/OREBP-V5 (Fig. 2B). The multiple bands in immunoblots
of MDC1 (Figs. 2, 3 and 4) apparently represent alternatively
spliced forms [19]. Interestingly, fewer bands of MDC1 are
coimmunoprecititated with TonEBP/OREBP than are present in
the input (Figure 2A). Perhaps, not all of the alternative splice
variants associate with TonEBP/OREBP. In order to test whether
the coimmunoprecipitation of MDC1 with TonEBP/OREBP
reflects mutual binding to DNA rather than protein-protein
interaction, we repeated anti-MDC1 immunoprecipitation in the
Table 1. MDC1 peptides identified by mass spectrometry.
Sequence Charge Xcorr
K.TPEPVVPTAPEPHPTTSTDQPVTP.K (aa 1607-1632) 3 4.3
R.AHEVGAQGGPPVAQVEQDLPISR.E (aa 619-643) 3 5.1
R.AMPVPTTPEFQSPVTTDQPISPEPITQPSCIKR.Q (aa 1690-1724) 3 5.3
R.ENLTDLVVDTDTLGESTQPQREGAQVPTGR.E (aa 642-673) 3 4.7
R.SSGKTPETLVPTAPKLEPSTSTDQPVTPEPTSQATR.G (aa 1398-1435) 3 5.8
R.SSVKTPEPVVPTAPELQPSTSTDQPVTSEPTSQVTR.G (aa 1152-1189) 3 7.4
R.SSVKTPEPVVPTAPELQPSTSTDQPVTSEPTYQATR.G (aa 1234-1271) 3 5.7
R.SSVKTPESIVPIAPELQPSTSR.N (aa 1562-1585) 3 4.1
R.SSVKTPETVVPTAPELQASASTDQPVTSEPTSR.T (aa 1480-1514) 3 6.1
K.KHQVSVEGTNQTDVK.A (aa 539-555) 3 3.9
K.TPETLVPTAPK.L (aa 1402-1414) 2 3.6
R.VGLPLLSPEFLLTGVLK.Q (aa 2054-2072) 2 4.2
R.IPATPVVIPMK.K (aa 337-349) 2 3.1
R.LLLAEDS*EEEVDFLSER.R (aa 161-179) 2 4.4
R.SQPPGEDS*DT*DVDDDSRPPGRPAEVHLER.A (aa 291-321) 3 3.3
R.SSVKT*PEPVVPTAPEPHPTTSTDQPVTPK.L (aa 1603-1633) 3 3.8
R.KSQLPAEGDAGAEWAAAVLKQER.A (aa 596-620) 3 6.1
R.TNMSSVKNPESTVPIAPELPPSTSTEQPVTPEPTSR.A (aa 1354-1391) 3 5.9
K.VLFTGVVDAR.G (aa 1894-1905) 2 2.7
R.DAEEDMPQR.V (aa 429-439) 2 3.2
Xcorr is the SEQUEST peptide cross-correlation score. XCorr values above 2.0 indicate a good identification. The charges on the ions are indicated.
doi:10.1371/journal.pone.0012108.t001
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and disrupts protein-DNA interactions [20]. Since the presence of
100 mg/ml ethidium bromide does not interrupt the coimmuno-
precipitation of MDC1 and TonEBP/OREBP-V5, we conclude
that MDC1 and TonEBP/OREBP are physically associated by
protein-protein interaction.
High NaCl decreases total abundance of MDC1, but
increases its soluble fraction
Increasing osmolality from 300 to 400 or 500 mosmol/kg by
adding NaCl for 2 hours reduces chromatin-bound MDC1 and
increases the soluble fraction (Fig. 3A), while decreasing the total
abundance of MDC1 (Fig. 3B). However, when the osmolality is
returned to 300 mosmol/kg, there is a large increase of chromatin-
bound MDC1 (Fig. 3C). We also observed the same increase in
HeLa cells (data not shown).
Effect of MDC1 on TonEBP/OREBP transcriptional activity
We used an ORE-X luciferase reporter stably expressed in
HEK293 cells to measure TonEBP/OREBP transcriptional activity.
Raising osmolality from 300 to 500 mosmol/kg by adding NaCl
increases the reporter activity more than 650-fold (Fig. 4A). We
knocked MDC1 down with specific small interfering RNAs (siRNAs).
25 nM of MDC1 siRNA-1 decreases MDC1 abundance by
approximately 80–90% (Fig. 4A). This specific siRNA reduces
TonEBP/OREBPtranscriptionalactivityby69%comparedtoanon
targeting control siRNA at 500 mosmol/kg, but has no significant
effect at 300 mosmol/kg (Fig. 4A). Similarly, MDC1 siRNA-2
reduces TonEBP/OREBP transcriptional activity by 70% compared
to the non targeting siRNA (mean of 2 independent experiments,
data not shown). The fact that siRNAs targeting different parts of
MDC1 have the same effect makes it unlikely that it is an off target
effect. A stably transfected reporter that does not contain any ORE
sequence served as control for specificity of the effect to TonEBP/
OREBP.HighNaCldoesnotincrease activityofthiscontrolreporter
and siRNA knockdown of MDC1 does not affect it significantly
(Fig.4B).Weconclude thatMDC1contributestohighNaCl-induced
increase of TonEBP/OREBP transcriptional activity.
Effect of MDC1 on TonEBP/OREBP transactivating activity
We used a binary TonEBP/OREBP TAD luciferase reporter
stably expressed in HEK293 cells to measure TonEBP/OREBP
transactivating activity. Raising osmolality from 300 to 500 mos-
mol/kg by adding NaCl increases the reporter activity 13-fold
(Fig. 4C). Knockdown of MDC1 by the specific siRNA-1 decreases
TonEBP/OREBP transactivating activity by 60% at 500 mos-
mol/kg, but has no significant effect at 300 mosmol/kg (Fig. 4C).
We also used a stable cell line with a reporter that does not contain
the TonEBP/OREBP TAD as a control for specificity of the effect
to TonEBP/OREBP. High NaCl does not increase activity of this
control reporter and siRNA knockdown of MDC1does not affect it
significantly (Fig. 4D). We conclude that MDC1 contributes to
high NaCl-induced increase of TonEBP/OREBP transactivating
activity.
Lack of effect of knockdown of MDC1 on nuclear
localization of TonEBP/OREBP
We measured TonEBP/OREBP protein by Western analysis of
nuclear and cytoplasmic extracts in order to calculate its nuclear to
cytoplasmic ratio Fig. 5A). The nuclear to cytoplasmic ratio of
TonEBP/OREBP varies directly with NaCl concentration, and
knocking down MDC1 with specific siRNA-1 has no significant
effect on the ratio at 200, 300, or 500 mosmol/kg (Fig. 5A).
Antibodies to BRG1 and aldose reductase serve as controls for
nuclear and cytoplasmic fractionation, respectively (Fig. 5A).
High NaCl decreases the nuclear to cytoplasmic ratio of
soluble MDC1
We measured MDC1 protein by Western analysis of nuclear
and cytoplasmic extracts in order to calculate its nuclear to
cytoplasmic ratio (Fig. 5B). Note that the extraction method used
does not extract chromatin-bound proteins.
Lack of evidence for an effect of high NaCl on
phosphorylation of MDC1
MDC1 becomes hyper phosphorylated in response to IR, as
demonstrated by a retardation of its mobility in SDS-PAGE that is
inhibited by phosphatase treatment of the protein extracts [19,21–
23]. The hyper phosphorylation is dependent on ATM and NBS1.
We do not find gel retardation of MDC1 in response to high NaCl
(Figs. 3 and 5B), but since the method is relatively insensitive, we
cannot entirely exclude the possibility.
Lack of effect of knockdown of MDC1 on ATM
ATM is a DNA damage response protein that is activated by
phosphorylation on Ser1981 [24]. Suppression of MDC1
Figure 1. Identification of MDC1 in immunoprecipitates of TonEBP/OREBP-1-547-V5 by mass spectrometry. MS
2 spectra of four MDC1
peptides. The arrows indicate ions that are site determining for phosphorylation.
doi:10.1371/journal.pone.0012108.g001
Table 2. MDC1 phosphopeptides identified by mass spectrometry.
Sequence Charge Xcorr Phosphosite Ascore
R.LLLAEDS*EEEVDFLSER.R (aa 161-179) 2 4.37 S168 153.33
R.SQPPGEDS*DT*DVDDDSRPPGRPAEVHLER.A (aa 291-321) 3 3.33 S299 43.85
T301 56.79
R.AQPFGFIDS*DTDAEEER.I (aa 320-338) 3 4.95 S329 38.66
R.SQTTTERDS*DT*DVEEEELPVENR.E (aa 444-468) 3 5.32 S453 26.79
T455 42.62
Xcorr is peptide cross-correlation score. Ascore measures the probability of correct identity of the phosphorylation sites. Asterisks indicate phosphorylation of the
preceding residues.
doi:10.1371/journal.pone.0012108.t002
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damaged by ionizing radiation (IR) [25]. Since high NaCl
damages DNA and increases phosphorylation of ATM on
Ser1981 [11,26], we supposed that MDC1 might reduce the
phosphorylation of ATM in response to high NaCl, like it does in
response to IR. However, when we knock down MDC1 by 80–
90% with the specific siRNA, there is no significant effect at any
osmolality on phosphorylation of ATM on Ser1981 (Figure 5C).
Discussion
TonEBP/OREBP is part of a large protein complex [3]. Many
proteins in this complex are known contribute to regulation of
TonEBP/OREBP, including PKAcs [10], PARP1 [12], Jun, Fos
[13], RHA [14] and ATM [11]. In the present studies we find that
MDC1 also is physically associated with TonEBP/OREBP
(Figures 1, 2A, and 2B and Table 1) and contributes to its
activation by high NaCl (Figures 4A and 4C). The complex
containing TonEBP/OREBP and MDC1 apparently is preassem-
bled since MDC1 coimmunoprecipitates with TonEBP/OREBP
whether NaCl is elevated or not (Fig. 2A), as do other TonEBP/
OREBP-associated proteins [12]. Evidently, high NaCl is not
required for assembly of the large complex containing TonEBP/
OREBP and the proteins that contribute to its osmotic regulation.
MDC1 works with H2AX to promote recruitment of repair
proteins to the sites of DNA breaks [22]. High NaCl increases
DNA breaks [27,28] and alters chromosome structure [29].
Several other DNA damage response proteins also physically
associate with TonEBP/OREBP, including DNA-PKcs (PRKDC)
[12], Ku86 (XRCC5) [12], ATM [11], and PARP1 [12]. Further,
ATM [11], PARP1[12], and MDC1 (present studies) all contribute
to regulation of high NaCl-induced activation of TonEBP/
OREBP. ATM is activated by high NaCl (determined from
increased phosphorylation at S1981) and contributes to the high
NaCl-induced increases of TonEBP/OREBP transcriptional
activity [11], transactivating activity [11], and nuclear localization
[30]. Although MDCI contributes to high NaCl-induced increase
in TonEBP/OREBP transcriptional (Figure 4A) and transactivat-
ing activity (Figure 4C), it does not contribute to the nuclear
localization (Figure 5A). ATM is a critical DNA repair protein,
consistent with its activation in direct response to DNA damage.
However, it may not be the DNA damage, itself, but the associated
changes in chromatin that activate ATM in response to IR [31]
and high NaCl.
High NaCl inhibits repair of DNA breaks caused by ultraviolet
radiation (UV) [32], as well as the breaks caused by the high NaCl,
Figure 2. Confirmation by Western analysis of identification of
MDC1 in immunoprecipitates of TonEBP/OREBP-1-547-V5.
‘‘Input’’ is the protein extract before immunoprecipitation. A. Osmo-
lality bathing HEK 293 cells stably transfected with TonEBP/OREBP-1-
547-V5 or empty vector-V5 (EV) was raised from 300 to 500 mosmol/kg
by adding NaCl for 1, 3 and 6 h. Proteins were immunoprecipitated with
rabbit IgG or anti-V5 antibodies and immunoblotted with anti-V5 or
anti-MDC1 antibody. B. Osmolality bathing HEK 293 cells stably
transfected with TonEBP/OREBP-1-547-V5 or empty vector-V5 was
raised from 300 to 500 mosmol/kg by adding NaCl for 2 h. Proteins
were immunoprecipitated from nuclear lysates with rabbit IgG or anti-
MDC1 and immunoblotted with anti-MDC1 or anti-V5 antibody. C.
100 mg/ml ethidium bromide was added during immunoprecipitation
with anti-MDC1 from nuclear extracts of the stably transfected HEK293
cells expressing TonEBP/OREBP-1-547-V5.
doi:10.1371/journal.pone.0012108.g002
Figure 3. Effect of high NaCl on MDC1 abundance and
distribution. HEK293 cells were exposed to media of the indicated
total osmolalities (NaCl varied) for 2 h. A. High NaCl increases the
abundance of MDC1 in the soluble fraction and decreases it in the
chromatin-bound fraction. (n=3, *P,0.05, t test). B. High NaCl
decreases total MDC1 abundance (n=3, *P,0.05, t test). C. After 2 h
of exposure to high NaCl medium osmolality was decreased to
300 mosmol/kg for 30 min. MDC1 returns to the chromatin-bound
fraction within that time (representative of 2 experiments).
doi:10.1371/journal.pone.0012108.g003
MDC1 Activates TonEBP/OREBP
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remains high, they are rapidly repaired when the NaCl is lowered
[27]. Further, the response of many damage response proteins to
high NaCl-induced DNA breaks differs from their response to IR
or UV. High NaCl, like IR or UV, activates ATM [11], but it does
not induce cH2AX (phosphorylated histone H2AX) [32,33] unless
the level of salt is raised enough to kill the cells by apoptosis [33].
Also, high NaCl does not induce formation of MRN foci,
composed of MRE11, RAD50 and NBS1 [33], and it reversibly
inhibits induction of cH2AX by UV or IR [32].
MDC1 becomes partially immobilized to chromatin and
recruits other DNA damage response proteins to the sites of
DNA damage during repair of DNA breaks caused by IR [34]. In
contrast, although high NaCl increases DNA breaks, it reduces the
fraction of MDC1 bound to chromatin (Fig. 3A and C). A critical
difference is that high NaCl inhibits DNA repair [27], inhibiting
activation of DNA repair proteins, like cH2AX and reducing
recruitment of the MRN complex to foci at the breaks [32]. We
propose that exclusion of MDC1 from chromatin contributes to
the inhibition by high NaCl of repair of DNA breaks. On the other
hand, high NaCl-induced DNA breaks are rapidly repaired when
NaCl is lowered [27]. The repair is accompanied by activation of
DNA damage response proteins, like cH2AX, MRE11, and
Chk1[27]. Accompanying that repair, the fraction of MDC1
bound to chromatin also increases dramatically (Figure 3C). We
suggest that much of the increased binding of MDC1 occurs at the
sites of DNA damage and contributes to their repair.
In so far as osmotic regulation of TonEBP/OREBP by MDC1
depends on their physical association and the transcriptional
activity of TonEBP/OREBP depends on its binding to specific
DNA elements [3,4] the high NaCl-induced reduction of the
fraction of MDC1 that is bound to chromatin (Figure 3) appears
paradoxical. However, recall that MDC1 has at least two roles; it
is both a DNA damage response protein and an osmotic regulator
of TonEBP/OREBP. High NaCl inhibits DNA repair and reduces
binding to DNA of repair proteins, including MDC1 (see above).
Nevertheless, that leaves a substantial amount of MDC1 still
bound to chromatin (Figure 3A), and the association of MDC1
with TonEBP/OREBP does remain intact (Figures 2A,B). We
suggest that high NaCl-induced solubilization of chromatin-bound
MDC1 could occur from pools not associated with TonEBP/
OREBP, leaving MDC1 still associated with the TonEBP/
OREBP bound to its specific DNA elements. On the other hand,
regulation of TonEBP/OREBP by MDC1 does not necessarily
require that they are bound together to DNA. TonEBP and
MDC1 interact in the soluble fraction from the cells (Figure 2),
and TonEBP/OREBP that is activated in the soluble fraction
could subsequently bind to chromatin where it could activate
transcription. An additional consideration is that release of MDC1
from chromatin near TonEBP/OREBP DNA elements could
promote access of TonEBP/OREBP to those elements. The
elements could be masked by proteins like MDC1, MRE11, Nbs1,
and Rad51, that are released from chromatin when NaCl is
elevated [35]. Also, release of MDC1 from chromatin could
change chromatin conformation in a way specific for high NaCl.
In so far as DNA damage and/or changes in chromatin
promote the role of ATM [5] and MDC1 in high NaCl-induced
activation of TonEBP/OREBP, those changes might serve as
sensors for hypertonicity. In this context it would be interesting to
know whether DNA-PK and Ku86, which also physically associate
with TonEBP/OREBP [12], have a similar role. Expression of
Ku86, is already known to provide osmoprotection by an
additional mechanism. It reduces high NaCl-induced chromo-
somal breakage, presumably by bridging broken DNA ends [35].
IR and UV do not directly activate TonEBP [11], so, any role of
DNA damage in activating TonEBP/OREBP requires the context
of hypertonicity.
In conclusion, we find the hypothesis attractive that high NaCl-
induced increase in DNA breaks or alteration of chromatin
structure provides a signal for the activation of TonEBP/OREBP
through DNA damage response proteins, but we recognize that
direct link between changes in DNA integrity and/or chromatin
structure induced by high NaCl and activation of TonEBP/
OREBP remains conjectural.
Materials and Methods
Plasmids and siRNA
Human TonEBP/OREBP cDNA clone KIAA0827 was a gift
from Dr. Takahiro Nagase (Kazusa DNA Research Institute,
Chiba, Japan). Sequence coding for amino acids 1–547 of
KIAA0827 was cloned into expression vector pcDNA6V5-His
(Invitrogen, Carlsbad, CA) to generate 1–547 V5-His as previously
described [12]. The ORE-X luciferase reporter construct (used to
Figure 4. Effect on TonEBP/OREBP transcriptional and trans-
activating activities of knocking down MDC1 expression. A.
HEK293 cells stably expressing an ORE-X reporter were transiently
transfected with 25 nM of siRNA against MDC1 or control siRNA for
48 hours. Then, the osmolality of medium was changed to 500 mosm/
kg by adding NaCl or kept at 300 mosmol/kg, and reporter activity was
measured 24 h later. Knock down of MDC1 is shown in the upper panel.
ORE-X reporter activity is relative to ‘‘control’’ at 300 mosmol/kg. B.
Control for specificity for ORE. Same as (A) except using an IL2 min
reporter (no ORE-X DNA element). C. Same as (A) except using HEK293
stably expressing the binary GAL4dbd TAD reporter and measuring
luciferase activity 16 hours after adjusting osmolality. D. Control for
specificity for TonEBP/OREBP TAD. Same as (C) except using HEK293
cells stably transfected with Gal4 DBD (no TAD). Mean 6SEM, *, P,0.01,
n=3.
doi:10.1371/journal.pone.0012108.g004
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PLoS ONE | www.plosone.org 6 August 2010 | Volume 5 | Issue 8 | e12108Figure 5. A. Lack of effect of siRNA-mediated knockdown of MDC1 on nuclear localization of TonEBP/OREBP. HEK 293 cells were transiently
transfected with 25 nM MDC1 siRNA or control siRNA. 48 h later the osmolality of medium was changed to 200 or 500 mosmol/kg or kept at
300 mosmol/kg for 1 h. Nuclear and cytoplasmic extracts were prepared. TonEBP/OREBP nuclear/cytoplasmic ratio was calculated from its
abundance in nuclear and cytoplasmic extracts. Antibodies to BRG1 and aldose reductase serve as controls for nuclear and cytoplasmic fractionation,
respectively. B. High NaCl decreases the nuclear localization of MDC1. Osmolality was changed to 200 or 500 mosmol/kg or kept at 300 mosmol/kg
for 1 h. Nuclear and cytoplasmic extracts were prepared. MDC1 nuclear/cytoplasmic ratio was calculated from its abundance in nuclear and
cytoplasmic extracts. C. Lack of effect of siRNA-mediated knockdown of MDC1 on phosphorylation of ATM on Ser1981. As in (A), except that
abundance of ATM was measured in whole cell extracts by Western analysis using a non-phosphospecific antibody and its phosphorylation on
Ser1981 was measured using phosphospecific anti-ATM 1981S-P antibody. Results are presented as the ratio of phosphorylated to non
phosphorylated ATM. (* P,.05, compared to 300 mosmol).
doi:10.1371/journal.pone.0012108.g005
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copies of human ORE-X [36] within a minimal IL-2 promoter
[37] (hTonE-GL3, a gift from S. N. Ho, University of California at
San Diego, La Jolla, CA). The control reporter (IL-2 min) does not
contain any ORE sequence. The binary reporter system used to
measure transactivating activity of TonEBP/OREBP consists of 1)
a GAL4 reporter plasmid pFR-Luc (Stratagene, La Jolla, CA),
containing five tandem repeats of the yeast GAL4 binding site
(upstream activating sequence) upstream of a minimal promoter
(TATATA) and the P. pyralis luciferase gene [7] and 2) GAL4dbd-
TonEBP/OREBP, which contains the yeast GAL4 DNA binding
domain (dbd) fused to sequence coding for amino acids 548–1531
of TonEBP/OREBP, which contain a NaCl-dependent TAD [7].
The control reporter, GAL4dbd, contains no TAD, but expresses
the GAL4dbd (pFC2-dbd, Stratagene, La Jolla, CA).
We modified the siRNA previously used to knock down MDC1
[22,38] to a synthetic dsRNA Dicer substrate to enhance the RNA
interference potency and efficacy [39]. The control (nontargeting)
siRNA (Integrated DNA Technologies, Coralville, IA) duplex
sequences were: sense, 59-Phos-UGAACCUGACCCAGGGGA-
GGGAGdTdT-39 and antisense sequence 59-AACUCCCUCCC-
CUGGGUCAGGUUCAUU-39. The MDC1 siRNA (Integrated
DNA Technologies, Coralville, IA) sequences were: sense for
MDC1 siRNA1-59- Phos-UCCAGUGAAUCCUUGAGGUGU-
AACGdTdT-39, for MDC1 siRNA2 – 59-Phos-GUCUCCCAGA-
AGACAGUGAUUAUCAdTdT-39 and, antisense for siRNA1 –
59-CGUUACACCUCAAGGAUUCACUGGAUU-39, for siRN-
A2 – UGAUAAUCACUGUCUUCUGGGAGACUU-39.
Cell Culture and Treatment
HEK293 cells (American Type Culture Collection, ATTC,
Manassas, VA) in passages 38–48 were cultured at 300 mosmol/
kg in media recommended by ATCC. At experiment-specific time
points, the medium was replaced with ones that were 300 mos-
mol/kg, 200 mosmol/kg (NaCl added to NaCl-free medium,
Biofluids, Rockville, MD), or 500 mosmol/kg (NaCl added).
HEK293 cells stably expressing TonEBP/OREBP 1-547 V5-His
and stable HEK293 TonEBP/OREBP reporter cell lines were
previously described [30,40].
Western Blot Analysis
Cells were lysed with a buffer containing 50 mM Tris-HCl,
pH 8.0, 150 mM NaCl, 1% Triton X-100 for whole-cell extracts
or with NE-PER (Nuclear and cytoplasmic Extraction Reagents;
Pierce Biotechnology, Rockford, IL), according to supplier’s
instructions, for separate nuclear and cytoplasmic fractions. A
protease inhibitor mixture (Roche Diagnostics, Indianapolis, IN)
and phosphatase inhibitor cocktails I and II (Sigma-Aldrich, St.
Louis, MO) were included in the lysis buffers. Proteins were
separated on 4–12% Novex Tris- Glycine gels and transferred to
nitrocellulose membranes (Invitrogen, Carlsbad, CA). Western
blot analysis was performed according to instructions for the
Odyssey Infrared Imaging System (Li-Cor, Lincoln, NE). In brief,
nonspecific binding was blocked by incubating membranes for 1 h
at 4uC with Odyssey Blocking Buffer diluted 1:1 with PBS.
Membranes then were incubated with rabbit anti-NFAT5
(TonEBP/OREBP) (Affinity BioReagents, Golden, CO), mouse
anti-V5 (Invitrogen, Carlsbad, CA), rabbit anti-MDC1 (Bethyl
Laboratories, Montgomery, TX), mouse anti-ATM (Santa Cruz
Biotechnology, Santa Cruz, CA), goat anti-aldose reductase (Santa
Cruz), mouse anti-BRG1 (Santa Cruz) or rabbit anti-P-ATM
(Rockland Immunochemicals, Gilbertsville, PA) at 4uC overnight.
After washing with 0.1% Tween-20 in PBS, blots were incubated
with Alexa Fluor 680 goat anti-rabbit IgG or Alexa Fluor 780 goat
anti-mouse IgG (Molecular Probes, Carlsbad, CA) for 1 h in the
dark. Blots were visualized and quantitated by using a Li-Cor
Odyssey Infrared Imager (Li-COR Biosciences, Lincoln, NE).
Transfection and Luciferase Assays
25 nM of siRNA specific for MDC1 or a control siRNA was
transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA),
according to supplier’s instructions. 48 hours later the osmolality
was either kept at 300 mosmol/kg or was increased to 500 mos-
mol/kg (NaCl added). Luciferase activity was measured with the
Luciferase Assay System (Promega, Madison, WI) 24 h later for
TonEBP/OREBP transcriptional activity (ORE-X reporter) or
16 h later for its transactivating activity (TAD reporter [7]). Total
protein was measured with the BCA Protein Assay Kit (Pierce,
Rockford, IL).
Calculation of Nuclear/Cytoplasmic Ratios
The relative amounts of TonEBP/OREBP and MDC1 in the
cytoplasmic and nuclear fractions and the nuclear/cytoplasmic
ratio were calculated from their concentrations in cytoplasmic and
nuclear extracts and the relative volumes of the extracts [41].
Isolation of soluble and non-soluble proteins, Western
blotting and Immunodetection
Cells were rinsed with phosphate-buffered saline (PBS), adjusted
with NaCl to the same osmolality as the medium, then lysed with
RIPA lysis buffer (50 mM Tris-HCl, 1% Igepal CA630, 150 mM
NaCl, 1 mM EDTA, 1 mM NaF, 1 mM Na3VO4, and protease
inhibitors (Roche Diagnostics)). The lysates were placed in ice for
10 min. Insoluble constituents were pelleted by centrifugation at
3,000 RCF. Supernatants containing proteins soluble in the RIPA
buffer were transferred to separate tubes and protein concentra-
tion was measured using the BCA Protein Assay (Pierce, Rockford,
IL). Insoluble pellets were boiled for 5 min in 40 ml of Laemmli
Sample buffer to denature the proteins and release them from the
pellet. After centrifugation at 15,000 RPM, the proteins in the
supernatant were identified by Western analysis. Loading of the
gels was normalized to equal masses of cells, calculated from the
amounts of soluble proteins in the corresponding fractions. To
calculate Bound to Soluble ratio for MDC1, the amount of MDC1
in the bound fraction (IFbound (Vbound (total))/Vbound(loaded)) was
divided by amount of MDC1 in soluble fraction (IFsoluble (Vsoluble
(total))/Vsoluble (loaded)), where V(loaded) is volume of the sample
loaded on the gel, V(total) is volume of entire fraction and IF is
Integral Fluorescence measured from corresponding band on
immunoblot. To prepare whole cell extracts, cells were rinsed with
phosphate-buffered saline (PBS), adjusted with NaCl to the same
osmolality as the medium, then lysed with RIPA buffer. 3X
Laemmli Sample buffer was added to the lysates and samples were
boiled for 5 minutes. Samples were loaded according to protein
concentration measured before addition of Laemmli buffer and
equal loading was verified by Coomassie Blue staining of the gels.
Immunoprecipitation and sample preparation for mass
spectrometry
HEK 293 cells stably transfected with TonEBP/OREBP 1-547
V5-His were grown in 15-cm dishes. Osmolality was increased to
500 mosmol/kg or decreased to 200 mosmol/kg by adjusting
NaCl for 2 h, then nuclear and cytoplasmic extracts were
prepared with Ne-PER (Pierce, Rockford, IL) according to the
supplier’s instructions, with added protease inhibitor cocktail
(Roche Applied Science, Germany) and phosphatase inhibitor
cocktail I and II (Sigma, St. Louis, MO). Extracts were pre-cleared
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Cruz Biotechnology, Carlsbad, CA) on Dynabeads (Invitrogen.
Pre-cleared supernatants were incubated overnight with rabbit
anti-V5 biotin-conjugated antibodies (ICL, Inc, Newberg, OR) on
Dynabeads. Beads were washed 3 times with buffer containing
50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Triton X-100,
then 3 times with phosphate buffered saline containing 1% Triton
X-100. Both buffers included phosphatase and protease inhibitor
cocktails. The beads were resuspended in 6 M guanidine-HCl/
50 mM NH4HCO3, to denature the proteins and elute them from
the beads. Proteins were reduced with 100 mM DTT for 1 h at
56uC, then alkylated using 100 mM iodoacetamide for 1 h at
room temperature in the dark. The sample buffer was exchanged
to 50 mM NH4HCO3 for trypsin digestion and to 100 mM Tris-
HCl, 10 mM CaCl2, pH 7.6 for endoproteinase Arg-C digestion,
using Amicon Ultra Centrifugal Filter Devices (Millipore Corpo-
ration Billerica, MA). Samples were digested with 1:50 wt/wt
trypsin (Promega, Madison, WI) or endoproteinase Arg-C (Roche
Applied Science, Germany) overnight at 37uC. The resulting
peptides were desalted using a 1-ml hydrophilic-lipophilic-
balanced (HLB) cartridge (Oasis, Milford, MA), followed by
volume reduction in vacuo. Each sample was subsequently
resuspended in 50 ml of 5% acetic acid, pH 2.5–3.0, then loaded
onto an IMAC column (Pierce, Rockford, IL) for phosphopeptide
enrichment. Peptides were incubated with the Ga 3+ resin in the
column for 20 min with gentle agitation every 5 min, then washed
and eluted as recommended by the supplier. Both flow through
and eluate were analyzed. Samples were dried in vacuo,
resuspended in 1% formic acid, and desalted with C18 Ziptips
(Millipore Corporation, Billerica, MA) before analysis by MS.
Immunoprecipitation of MDC1 utilized anti-MDC1 (Bethyl
Laboratories, Montgomery, TX) on A/G PLUS-agarose beads.
Mass spectrometry
Peptides in the flow-through fractions from IMAC columns and
eluates from the columns were analyzed on an Agilent 1100
nanoflow system (Agilent Technologies, Palo Alto, CA) LC
connected to a Finnigan LTQ mass spectrometer (Thermo
Electron, San Jose, CA) equipped with a nanoelectrospray ion
source. MS spectra were analyzed with the SEQUEST search
algorithm in BIOWORKS software (Thermo Electron), to identify
peptides. Peak masses were searched against the most current
version of the Human Refseq Database (National Center for
Biotechnology Information) and its reversed complement with the
following parameters: fixed carbamidomethylation of Cys; variable
phosphorylation of Ser, Thr, and Tyr. We used the target-decoy
approach for matches to the MS
2 spectra with a concatenated
database that includes both forward and reversed sequences. The
target-decoy approach estimates false discovery rates based on the
principle that incorrect spectral matches have an equal probability
of occurring in either the forward (‘‘target’’) or reversed (‘‘decoy’’)
database. We used PhosphoPIC [42] to select for minimum cross-
correlation (Xcorr) settings high enough to reduce the target false
positive rate to less than 5%. All *.dta and *.out files from the
SEQUEST search were included in the filtered dataset. The
(XCorr) filter was automatically adjusted for each individual
charge state (+1, +2, +3) to meet predetermined target false
discovery rate, based on the number of allowable random matches
from the reversed ‘‘decoy’’ database. We used Ascore (http://
Ascore.med.harvard.edu) [43] to estimate the probability that the
phosphorylation sites are correctly identified, based on the
presence and intensity of site-determining ions in MS/MS spectra.
Ascore .19 predicts .99% probability of correct identification.
Statistical Analysis
Data were compared by t test or for multiple comparisons by
repeated measures ANOVA, followed by Bonferroni multiple
comparisons test. Normalized data were transformed prior to
statistical analysis. Differences were considered significant for
p#0.05.
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